Merrion Investment Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-2,100
Closed -$238K 108
2024
Q3
$238K Sell
2,100
-800
-28% -$95K 0.16% 93
2024
Q2
$361K Hold
2,900
0.25% 73
2024
Q1
$383K Hold
2,900
0.27% 72
2023
Q4
$316K Hold
2,900
0.25% 73
2023
Q3
$301K Hold
2,900
0.26% 69
2023
Q2
$335K Hold
2,900
0.28% 67
2023
Q1
$309K Hold
2,900
0.29% 63
2022
Q4
$324K Buy
+2,900
New +$296K 0.3% 59
2021
Q2
Sell
-3,144
Closed -$231K 94
2021
Q1
$231K Hold
3,144
0.19% 80
2020
Q4
$245K Buy
+3,144
New +$240K 0.21% 79

Other funds holding MRK

Merrion Investment Management's MRK Position: Q4 2024 in Review

Merrion Investment Management sold out of Merck (MRK) in Q4 2024, closing a stake of 2,100 shares — an estimated $238K sold.

Merrion Investment Management first reported a position in MRK in Q4 2020 and held it in 10 quarters. The position peaked at $383K in Q1 2024. 3,608 funds tracked by Wall St. Rank hold MRK as of Q4 2024.

  • Merrion Investment Management reported no remaining Merck position as of Q4 2024 after selling out during the quarter.
  • Merrion Investment Management sold 2,100 Merck shares in Q4 2024, an estimated $238K.
  • Merrion Investment Management first reported a position in Merck in Q4 2020 and held it in 10 quarters.
  • Merrion Investment Management's Merck position peaked at $383K in Q1 2024.
  • 3,608 funds tracked by Wall St. Rank held Merck as of Q4 2024.

Based on Merrion Investment Management's 13F filing for Q4 2024, filed 23 Jan 2025.